123 results on '"Crawley, Charles"'
Search Results
2. Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
3. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT
4. Legionellosis after hematopoietic stem cell transplantation
5. Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT
6. Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance
7. Real‐world efficacy of single‐agent belantamab mafodotin in relapsed systemic AL amyloidosis.
8. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
9. Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
10. RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
11. Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation : A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
12. Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT.
13. High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry
14. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
15. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
16. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols
17. Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution
18. From Charts to Glyphs: Rudolf Modley's Contribution to Visual Communication.
19. The Outcome of Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia in First Remission Who Were Initially Refractory to First Induction Chemotherapy
20. A World without "Whom": The Essential Guide to Language in the BuzzFeed Age Favilla Emmy J.
21. Word by Word: The Secret Life of Dictionaries Stamper Kory
22. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
23. The Online Teaching Survival Guide: Simple and Practical Pedagogical Tips. 2 nd ed. Boettcher Judith V. Conrad Rita-Marie
24. The Book: A Cover-to-Cover Exploration of the Most Powerful Object of Our Time Houston Keith
25. Familial pseudohyperkalaemia Chiswick: a novel congenital thermotropic variant of K and Na transport across the human red cell membrane
26. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma
27. FAMILIAL FOLLICULAR LYMPHOMA: A CASE REPORT WITH MOLECULAR ANALYSIS
28. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
29. Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.
30. Sickle cell disease
31. Making a Point: The Persnickety Story of English Punctuation David Crystal
32. The Craft of Quoting: The Art of Writing it Like it's Said Frank Harris III
33. Reclaiming Conversation: The Power of Talk in a Digital Age Sherry Turkle
34. The Sceptical Optimist: Why Technology Isn't the Answer to Everything Nicholas Agar
35. A One Health Study of the Genetic Relatedness of Klebsiella pneumoniae and Their Mobile Elements in the East of England.
36. Words Onscreen: The Fate of Reading in a Digital World Baron Naomi S.
37. From Corporate to Social Media: Critical Perspectives on Corporate Social Responsibility in Media and Communication Industries Marisol Sandoval
38. From Charts to Glyphs: Rudolf Modley's Contribution to Visual Communication
39. Correspondence
40. Artline 2.0
41. On Paper: The Everything of Its Two-Thousand-Year History. 3rd ed. Basbanes Nicholas A.
42. Signs for Peace: An Impossible Visual Encyclopedia Ruedi Baur Vera Baur Kockot
43. How to Not Write Bad: The Most Common Writing Problems and the Best Ways to Avoid Them Ben Yagoda
44. Thou Shall Not Use Comic Sans. 365 Graphic Design Sins and Virtues: A Designer's Almanac of Dos and Don'ts Sean Adams Peter Dawson John Foster Tony Seddon
45. Vernacular Eloquence: What Speech Can Bring to Writing Peter Elbow
46. Otto Neurath: The Language of the Global Polis Nader Vossoughian
47. Symbol Angus Hyland Steven Bateman
48. Never Use More Than Two Different Typefaces: And 50 Other Ridiculous Typography Rules Anneloes van Gaalen
49. Concise Oxford English Dictionary. 12th ed. Angus Stevenson Maurice Waite
50. NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.